Absci Corporation

NasdaqGS ABSI

Absci Corporation Dividend Yield on February 06, 2025: 0.00%

Absci Corporation Dividend Yield is 0.00% on February 06, 2025, a 0.00% change year over year. Dividend yield measures the dividend per share relative to stock's price value; higher yield suggests higher dividend return.
  • Absci Corporation 52-week high Dividend Yield is 0.00% on February 06, 2025, which is 0.00% below the current Dividend Yield.
  • Absci Corporation 52-week low Dividend Yield is 0.00% on February 06, 2025, which is 0.00% below the current Dividend Yield.
  • Absci Corporation average Dividend Yield for the last 52 weeks is 0.00%.
Key data
Date Dividend Yield Free Cash Flow Yield Earnings Yield Enterprise Value (EV)
Market news
Loading...
SV Wall Street
NasdaqGS: ABSI

Absci Corporation

CEO Mr. Sean McClain
IPO Date July 22, 2021
Location United States
Headquarters 18105 SE Mill Plain Boulevard
Employees 155
Sector Healthcare
Industries
Description

Absci Corporation, a drug and target discovery company, provides biologic drug candidates and production cell lines using integrated drug creation platform for partners in the United States. Its integrated drug creation platform enables the creation of biologics by unifying the drug discovery and cell line development processes into one process. Absci Corporation was founded in 2011 and is headquartered in Vancouver, Washington.

Similar companies

ZURA

Zura Bio Limited

USD 1.77

-0.56%

INZY

Inozyme Pharma, Inc.

USD 1.50

-1.32%

RLAY

Relay Therapeutics, Inc.

USD 4.51

-5.85%

CRBU

Caribou Biosciences, Inc.

USD 1.42

-2.74%

ABOS

Acumen Pharmaceuticals, Inc.

USD 1.47

-4.54%

DAWN

Day One Biopharmaceuticals, Inc.

USD 12.51

2.37%

SANA

Sana Biotechnology, Inc.

USD 3.26

-1.81%

DTIL

Precision BioSciences, Inc.

USD 4.88

-1.21%

RXRX

Recursion Pharmaceuticals, Inc.

USD 7.24

-8.59%

StockViz Staff

February 7, 2025

Any question? Send us an email